| Fall 2017 | Speaker | Institution | Host | Title of Talk | Sponsored in part by: |
| 9/11/2017 | Anne Sperling, PhD | Department of Medicine, University of Chicago, Chicago IL | Vaiva Vezys | “Environmental effects on immunity and atopy/asthma risk: Lessons from Amish and Hutterite farm children” | BioLegend |
| 9/25/2017 | Jennifer Lund, PhD | Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA | David Masopust | "Modulation of anti-viral immunity: from mice to humans." | |
| 10/2/2017 | John Harty, PhD | Department of Microbiology and Immunology, University of Iowa College of Medicine, Iowa City, IA | Marc Jenkins | "Immune regulation during blood-stage malaria" | BioLegend |
| 10/16/2017 | Katie Haskins, PhD | University of Colorado Anschutz Medical Campus, Denver, CO | Brian Fife | "Hybrid Insulin Peptides: Neo-Antigens in Autoimmune Diabetes" | |
| 11/6/2017 | Diane Lidke, PhD | Department of Pathology, University of New Mexico, Albuquerque, NM | Tanya Freedman | "Quantifying the protein-protein interactions that regulate FceRI and pre-BCR signaling" | Miltenyi Biotec |
| 11/13/17 | Marion Pepper, PhD | Department of Immunology, University of Washington, Seattle, WA | Marc Jenkins | "The development and function of Plasmodium-specific Memory B cells" | |
| 12/4/2017 | Benjamin Youngblood, PhD | Immunology Department, St. Jude Children's Research Hospital, Memphis, TN | David Masopust and Vaiva Vezys | “Epigenetic regulation of memory T cell differentiation and exhaustion” | |
| 12/18/2017 | Douglas Green, PhD | Immunology Department, St. Jude Children's Research Hospital, Memphis, TN | Tom Griffith | "Targeting LAP: LC3-associated phagocytosis in inflammation and anti-cancer immunity" | BioLegend |
| Spring 2018 | | | | | |
| 2/12/2018 | Maureen Su, MD | Department of Microbiology and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC | Kris Hogquist | "Aire Expands: Central tolerance in autoimmunity and cancer" | |
| | | | | |
| 3/12/2018 | Ana Anderson, PhD | Department of Neurology, Harvard Medical School, Boston, MA | Mike Farrar | “Molecular determinants of T cell phenotypes in the tumor microenvironment” | Stemcell Technologies |
| 3/26/2018 | Aaron Michels, MD | School of Medicine, University of Colorado Anschutz Medical Campus, Denver, CO | Brian Fife | “Blocking MHC Class II Antigen Presentation for Type 1 Diabetes Prevention” | BioLegend |
| 4/9/2018 | Dan Barber, PhD | -Lymphocyte Biology Unit, National Institute of Allergy and Infectious Diseases, MD | David Masopust and Vaiva Vezys | “CD4 T cell responses to Mycobacterium tuberculosis infection” | |
| 4/23/2018 | Randolph Noelle, PhD | Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH | Bruce Blazer | "VISTA targeted therapy in cancer and autoimmunity" | BioLegend |